IP Library Granted Patent US 10,273,260
Granted Patent B2
US 10,273,260 · App. 15/373,260 · Granted Apr 30, 2019

Compounds and methods for treating bacterial infections

Inventors: James W. Janetka (St. Louis, MO); Zhenfu Han (St. Louis, MO); Scott Hultgren (St. Louis, MO); Jerome S. Pinkner (St. Louis, MO); Corinne Cusumano (St. Louis, MO)
Assignee: WASHINGTON UNIVERSITY
C07H15/20A01N43/10A01N43/16A01N43/38A01N43/42A01N43/52A01N43/54A01N43/76A01N43/78A01N47/36A01N55/08A61K31/505A61K31/706A61K31/7034A61K31/7042A61K31/7048A61K31/7056C07D309/10C07H15/203C07H15/207C07H15/22C07H15/26C07H19/056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,273,260
App. No.
15/373,260
Granted
Apr 30, 2019
Kind
B2
Abstract

The present invention encompasses compounds and methods for treating urinary tract infections.

Claims (20)

1. A compound of structural Formula XXIV

wherein:

X is selected from the group consisting of hydrogen, OD 2 , SD 2 , and ND z ;

Z is O 4 ;

Y is oxygen 4 ;

D 2 , D 4 , D 5 are independently selected from the group consisting of hydrogen, hydrocarbyl, and substituted hydrocarbyl;

n is an integer from 1 to 10;

A is independently selected from the group consisting of C, CD 6 and N;

D 6 is independently selected from the group consisting of hydrogen, hydrocarbyl, and substituted hydrocarbyl;

D 24 is selected from the group consisting of hydrogen, halogen, hydrocarbyl, and substituted hydrocarbyl;

D 25 and D 26 is selected from the group consisting of hydrogen, —NHCONH 2 , —COOMe, and —CONHMe, or D 25 and D 26 can optionally form a cycloalkyl or heterocyclo ring;

D z is independently selected from the group consisting of hydrogen hydrocarbyl, substituted hydrocarbyl, —COD x , —COND x D x SO 2 D x , and —CO 2 D x ; and

D x is independently selected from the group consisting of hydrogen, —ND 4 D 5 , or an optionally substituted alkyl, cycloalkyl, heterocycle, or aryl.

2. The compound of claim 1 , wherein X is OR 2 ; and Z is O.

3. The compound of claim 1 , wherein D 24 is hydrocarbyl.

4. The compound of claim 3 , wherein D 24 is methyl.

5. The compound of claim 1 , wherein D 25 and D 26 form a cycloalkyl or heterocyclo ring.

6. A method of treating a urinary tract infection, the method comprising administering a compound of claim 1 to a subject in need thereof.

7. The method of claim 6 , wherein the subject is further administered a bactericidal composition.

8. A method of reducing the resistance of a bacterium to a bactericidal compound, the method comprising administering a compound of claim 1 to a subject in need thereof.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE MIDDLE INITIAL OF INVENTOR CORINNE CUSSUMANO PREVIOUSLY RECORDED AT REEL: 042164 FRAME: 0802. ASSIGNOR(S) HEREBY CONFIRMS THE . Recorded May 1, 2017
From: JANETKA, JAMES W.; HULTGREN, SCOTT JAMES, PHD; PINKER, JERRY; HAN, ZHENFU; CUSUMANO, CORINNE K.
To: WASHINGTON UNIVERSITY
Reel/Frame 042375/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: JANETKA, JAMES W.; HULTGREN, SCOTT JAMES, PHD; PINKER, JERRY; HAN, ZHENFU; CUSUMANO, CORINNE C.
To: WASHINGTON UNIVERSITY
Reel/Frame 042164/0802 →
Continuity (10)
Division 14570322 · Dec 15, 2014
Division 13453991 · Apr 23, 2012
Continuation In Part PCTUS2010053848 · Oct 22, 2010
Continuation In Part PCTUS2012024169 · Feb 7, 2012
Provisional Application 61254135 · Oct 22, 2009
Provisional Application 61321738 · Apr 7, 2010
Provisional Application 61384535 · Sep 20, 2010
Provisional Application 61440260 · Feb 7, 2011
Provisional Application 61451455 · Mar 10, 2011
Related Publication 20170247401A1 · Aug 31, 2017
Cited By (3)
US 12,297,223 US 12,351,597 US 12,552,824